Cargando…

FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI/ML-based approaches

Detalles Bibliográficos
Autores principales: Zushin, Peter-James H., Mukherjee, Souhrid, Wu, Joseph C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Clinical Investigation 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617761/
https://www.ncbi.nlm.nih.gov/pubmed/37909337
http://dx.doi.org/10.1172/JCI175824
_version_ 1785129644208422912
author Zushin, Peter-James H.
Mukherjee, Souhrid
Wu, Joseph C.
author_facet Zushin, Peter-James H.
Mukherjee, Souhrid
Wu, Joseph C.
author_sort Zushin, Peter-James H.
collection PubMed
description
format Online
Article
Text
id pubmed-10617761
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher American Society for Clinical Investigation
record_format MEDLINE/PubMed
spelling pubmed-106177612023-11-01 FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI/ML-based approaches Zushin, Peter-James H. Mukherjee, Souhrid Wu, Joseph C. J Clin Invest Viewpoint American Society for Clinical Investigation 2023-11-01 /pmc/articles/PMC10617761/ /pubmed/37909337 http://dx.doi.org/10.1172/JCI175824 Text en © 2023 Zushin et al. https://creativecommons.org/licenses/by/4.0/This work is licensed under the Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Viewpoint
Zushin, Peter-James H.
Mukherjee, Souhrid
Wu, Joseph C.
FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI/ML-based approaches
title FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI/ML-based approaches
title_full FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI/ML-based approaches
title_fullStr FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI/ML-based approaches
title_full_unstemmed FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI/ML-based approaches
title_short FDA Modernization Act 2.0: transitioning beyond animal models with human cells, organoids, and AI/ML-based approaches
title_sort fda modernization act 2.0: transitioning beyond animal models with human cells, organoids, and ai/ml-based approaches
topic Viewpoint
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10617761/
https://www.ncbi.nlm.nih.gov/pubmed/37909337
http://dx.doi.org/10.1172/JCI175824
work_keys_str_mv AT zushinpeterjamesh fdamodernizationact20transitioningbeyondanimalmodelswithhumancellsorganoidsandaimlbasedapproaches
AT mukherjeesouhrid fdamodernizationact20transitioningbeyondanimalmodelswithhumancellsorganoidsandaimlbasedapproaches
AT wujosephc fdamodernizationact20transitioningbeyondanimalmodelswithhumancellsorganoidsandaimlbasedapproaches